Investment in Atlantic Therapeutics nears €50m as it names new CEO - News Summed Up

Investment in Atlantic Therapeutics nears €50m as it names new CEO


Total investment in Irish medtech Atlantic Therapeutics has risen to nearly €50 million with the company planning on seeking further funding early next year as it expands in the US. Based in Boston, she spent over 20 years with GlaxoSmithKline prior to joining the Irish company. Atlantic is a spin-out from Galway-based Bio-Medical Research Group, the company behind the well-known body toning belt product, Slendertone. Early last year it raised €28 million in a round led by LSP, one of Europe’s largest healthcare investment firms. With an estimated one in three women suffering from stress urinary incontinence, the potential market for Atlantic is significant.


Source: The Irish Times July 15, 2020 10:30 UTC



Loading...
Loading...
  

Loading...

                           
/* -------------------------- overlay advertisemnt -------------------------- */